chitosan has been researched along with warfarin in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (15.15) | 29.6817 |
| 2010's | 25 (75.76) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, CE; Huang, SS; Sung, SH | 1 |
| Kumirska, J; Malinski, E; Orlita, A; Paszkiewicz, M; Sidwa-Gorycka, M; Siedlecka, EM; Stepnowski, P; Łojkowska, E | 1 |
| Cheng, G; Chung, SJ; Cui, F; Kim, DD; Kim, IW; Shim, CK; Shim, WS; Yang, R; Yang, SG | 1 |
| Cheng, G; Chung, SJ; Cui, FD; Han, X; Jin, QR; Kim, DD; Shim, CK; Shim, WS; Yang, R | 1 |
| Bakowsky, U; Kissel, T; Sitterberg, J; Trapani, A | 1 |
| Bolden, G; Chinta, DM; Dash, S; Graves, RA; Hazari, S; Kishore, V; Mandal, TK; Pamujula, S | 1 |
| Bernkop-Schnürch, A; Iqbal, J; Sakloetsakun, D | 1 |
| Huang, A; Makhlof, A; Ping, Q; Takeuchi, H; Tozuka, Y | 1 |
| Cam Etöz, B; Işbil Büyükcoşkun, N; Köksal, O; Ozdemir, F; Sığırlı, D | 1 |
| Dong, S; Li, Z; Tang, H; Yu, Z; Zhou, Y | 1 |
| El-Banna, ST; El-Feky, GS; Khalil, SK; Khalil, WA | 1 |
| Guo, M; Hou, J; Lu, Y; Rong, WT; Wang, DF; Wang, Y; Xu, Q; Yu, SQ | 1 |
| Tahara, K; Takeuchi, H; Ying, L | 1 |
| Bei, YY; Chen, WL; Fan, YJ; Hu, XJ; Liu, Y; Wang, ZL; You, BG; Zhang, CG; Zhang, XN; Zhou, XF; Zhu, AJ; Zhu, QL | 1 |
| Chen, WL; Jin, Y; Liu, Y; Yang, SD; Yuan, ZQ; Zhang, CG; Zhang, XN; Zhou, XF; Zhou, Y; Zhu, AJ; Zhu, QL | 1 |
| Batoni, G; Chiellini, F; Esin, S; Maisetta, G; Piras, AM; Sandreschi, S | 1 |
| Alijanpour, SO; Asghari, S; Chaichi, MJ; Shadlou, S | 1 |
| Gholivand, MB; Mohammadi-Behzad, L | 1 |
| Cui, X; Li, Z; Liu, S; Wang, H; Wang, S; Xu, F; Yang, T; Zhao, T | 1 |
| Ernst, J; Fischer, D; Klinger-Strobel, M; Lautenschläger, C; Makarewicz, O; Pletz, MW | 1 |
| Song, X; Xiang, C; Yin, J | 1 |
| Cui, X; Feng, Y; Li, Z; Liu, Y; Shi, C; Wang, G; Zhang, H; Zhong, S | 1 |
| Cheng, B; Li, J; Liu, D; Pan, H; Wu, Q | 1 |
| Fan, S; Jin, Q; Wang, C; Xie, P; Xu, C; Yang, G | 1 |
| Cheng, B; Li, J; Liu, D; Pan, W; Tan, G | 1 |
| Je, HJ; Kim, ES; Lee, HG; Lee, JS | 1 |
| Jeong, YY; Lee, BI; Moon, MJ; Park, HJ; Park, IK; Surendran, SP; Thomas, RG | 1 |
| Sun, S; Yang, F; Zhou, K; Zhu, W | 1 |
| Ghandi, M; Khoee, S; Rahimi, S | 1 |
| Alirezvani, Z; Dekamin, MG; Valiey, E | 1 |
| Pai, RV; Vavia, PR | 1 |
| Guo, Y; Huang, G; Ma, Y; Pan, Y; Si, Y; Sun, J; Tu, P; Wang, L; Xu, G; Zheng, S | 1 |
| Bao, D; Cheng, C; Guo, J; Qing, M; Sun, S; Zhang, S; Zhao, M; Zhou, Y | 1 |
33 other study(ies) available for chitosan and warfarin
| Article | Year |
|---|---|
Chitosan potentiation of warfarin effect.
Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Chitosan; Chronic Disease; Diabetes Mellitus, Type 2; Drug Synergism; Humans; Hypertension; International Normalized Ratio; Male; Self Medication; Thrombosis; Vitamin K; Vitamins; Warfarin | 2007 |
Application of chitin and chitosan as elicitors of coumarins and fluoroquinolone alkaloids in Ruta graveolens L. (common rue).
Topics: Alkaloids; Chitin; Chitosan; Coumarins; Dose-Response Relationship, Drug; Fluoroquinolones; Plant Roots; Ruta | 2008 |
Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chitosan; Coumarins; Lactic Acid; Lung; Lung Neoplasms; Male; Mice; Nanoparticles; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties; Thiazoles | 2009 |
Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chitosan; Coumarins; Drug Carriers; Humans; Hydrogen-Ion Concentration; Lactic Acid; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Microscopy, Confocal; Nanoparticles; Neoplasm Transplantation; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Static Electricity; Thiazoles; Xenograft Model Antitumor Assays | 2009 |
The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs.
Topics: Caco-2 Cells; Chitosan; Coloring Agents; Coumarins; Cross-Linking Reagents; Cyclodextrins; Drug Carriers; Excipients; Fluorescence; Humans; Microscopy, Confocal; Nanoparticles; Particle Size; Polyphosphates; Solubility; Thiazoles | 2009 |
Preparation and in-vitro/in-vivo evaluation of surface-modified poly (lactide-co-glycolide) fluorescent nanoparticles.
Topics: Animals; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Chitosan; Coumarins; Drug Carriers; Female; Flow Cytometry; Fluorescence; Lactic Acid; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectrometry, Fluorescence; Surface Properties; Technology, Pharmaceutical; Thiazoles; Tissue Distribution | 2010 |
Thiomers: Inhibition of cytochrome P450 activity.
Topics: Aryl Hydrocarbon Hydroxylases; Chitosan; Coumarins; Cysteine; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Carriers; Drug Compounding; Drug Delivery Systems; Enzyme Assays; Enzyme Inhibitors; Excipients; Indicators and Reagents; Polymers; Sulfhydryl Compounds; Verapamil | 2011 |
N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin.
Topics: Administration, Oral; Animals; Blood; Bone Density Conservation Agents; Calcitonin; Calcium; Chitosan; Cholesterol; Coumarins; Drug Carriers; Hydrogen-Ion Concentration; Intestine, Small; Magnetic Resonance Spectroscopy; Male; Microscopy, Atomic Force; Mucins; Organophosphates; Particle Size; Phosphatidylcholines; Rats; Rats, Wistar; Static Electricity; Surface Properties; Thiazoles; Unilamellar Liposomes | 2011 |
Hemostatic effect of a chitosan linear polymer (Celox®) in a severe femoral artery bleeding rat model under hypothermia or warfarin therapy.
Topics: Animals; Anticoagulants; Chitosan; Disease Models, Animal; Female; Femoral Artery; Hemorrhage; Hemostatics; Hypothermia, Induced; Rats; Rats, Sprague-Dawley; Warfarin | 2011 |
Direct electrochemistry of hemoglobin immobilized in chitosan-room temperature ionic liquid film and application in its interaction with 3,4'-bis-(4-hydro-3-xycoumarin)-2,5-hexanediol.
Topics: Animals; Biosensing Techniques; Cattle; Chitosan; Coumarins; Electrochemical Techniques; Electrodes; Glycols; Hemoglobins; HIV Protease Inhibitors; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Immobilized Proteins; Ionic Liquids; Limit of Detection; Temperature | 2012 |
Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery.
Topics: Administration, Cutaneous; Anticoagulants; beta-Cyclodextrins; Chitosan; Drug Carriers; Nanoparticles; Particle Size; Warfarin | 2012 |
Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Topics: Absorption; Animals; Caco-2 Cells; Calorimetry, Differential Scanning; Camptothecin; Cell Death; Chitosan; Coated Materials, Biocompatible; Coumarins; Enterocytes; HT29 Cells; Humans; Intestines; Irinotecan; Kinetics; Lactic Acid; Male; Nanoparticles; Particle Size; Perfusion; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Rhodamine 123; Spectroscopy, Fourier Transform Infrared; Static Electricity; X-Ray Diffraction | 2013 |
Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: effect of emulsion formulations and surface modification.
Topics: Administration, Ophthalmic; Animals; Animals, Outbred Strains; Chemistry, Pharmaceutical; Chitosan; Coumarins; Emulsions; Lipids; Male; Mice; Ophthalmic Solutions; Poloxamer; Retina; Surface Properties; Thiazoles | 2013 |
Synthesis and characterization of low-toxicity N-caprinoyl-N-trimethyl chitosan as self-assembled micelles carriers for osthole.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chitosan; Coumarins; Diffusion; Drug Compounding; Humans; Micelles; Nanocapsules; Neoplasms, Experimental; Particle Size; Treatment Outcome | 2013 |
N-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein for targeted osthole-loaded delivery to low-density lipoprotein receptor-rich tumors.
Topics: Animals; Chitosan; Coumarins; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Lipoproteins; Mice; Mice, Nude; Nanocapsules; Nanoconjugates; Neoplasms, Experimental; Receptors, LDL; Treatment Outcome | 2014 |
Chitosan nanoparticles for the linear release of model cationic Peptide.
Topics: Antimicrobial Cationic Peptides; Chemistry, Pharmaceutical; Chitosan; Coumarins; Drug Carriers; Drug Compounding; Drug Liberation; Hydrophobic and Hydrophilic Interactions; Linear Models; Nanoparticles; Oligopeptides | 2015 |
Evaluation of luminol chemiluminescence based on simultaneous introducing of coumarin derivatives as green fluorophores and chitosan-induced Au/Ag alloy nanoparticle as catalyst for the sensitive determination of glucose.
Topics: Alloys; Catalysis; Chitosan; Coumarins; Glucose; Gold; Hydrogen Peroxide; Hydrogen-Ion Concentration; Limit of Detection; Luminescent Measurements; Luminol; Metal Nanoparticles; Silver; Succinic Acid | 2015 |
An electrochemical sensor for warfarin determination based on covalent immobilization of quantum dots onto carboxylated multiwalled carbon nanotubes and chitosan composite film modified electrode.
Topics: Adsorption; Adult; Animals; Biosensing Techniques; Blood Chemical Analysis; Chitosan; Conductometry; Equipment Design; Equipment Failure Analysis; Female; Humans; Microelectrodes; Milk; Nanocomposites; Nanotubes, Carbon; Quantum Dots; Urinalysis; Warfarin | 2015 |
Preparation of magnetic and pH-responsive chitosan microcapsules via sonochemical method.
Topics: Chitosan; Coumarins; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Hydrogen-Ion Concentration; Magnetics; Magnetite Nanoparticles; Oleic Acid; Particle Size; Sonication; Thiazoles | 2016 |
A blue fluorescent labeling technique utilizing micro- and nanoparticles for tracking in LIVE/DEAD® stained pathogenic biofilms of Staphylococcus aureus and Burkholderia cepacia.
Topics: Acetates; Biofilms; Burkholderia cepacia; Chitosan; Coumarins; Fluorescent Dyes; Lactic Acid; Microscopy, Confocal; Nanoparticles; Organic Chemicals; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Propidium; Staphylococcus aureus | 2016 |
Nanoencapsulation of psoralidin via chitosan and Eudragit S100 for enhancement of oral bioavailability.
Topics: Administration, Oral; Animals; Benzofurans; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Coumarins; Nanocapsules; Polymethacrylic Acids; Random Allocation; Rats; Rats, Sprague-Dawley | 2016 |
Folic acid functionalized reduction-responsive magnetic chitosan nanocapsules for targeted delivery and triggered release of drugs.
Topics: Chitosan; Coumarins; Drug Delivery Systems; Drug Liberation; Folic Acid; HeLa Cells; Humans; Magnetics; Nanocapsules; Thiazoles | 2017 |
Ex Vivo and in Vivo Evaluation of the Effect of Coating a Coumarin-6-Labeled Nanostructured Lipid Carrier with Chitosan-N-acetylcysteine on Rabbit Ocular Distribution.
Topics: Acetylcysteine; Animals; Chitosan; Cornea; Coumarins; Drug Carriers; Eye; Lipids; Nanoparticles; Nanostructures; Rabbits; Thiazoles | 2017 |
Synthesis, characterization and antifungal activity of coumarin-functionalized chitosan derivatives.
Topics: Alternaria; Carbohydrate Sequence; Chitosan; Coumarins; Fungicides, Industrial; Fusarium; Microbial Sensitivity Tests; Plant Diseases; Semicarbazides | 2018 |
Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Topics: Acetylcysteine; Administration, Ophthalmic; Animals; Chitosan; Cornea; Coumarins; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Excipients; Lipids; Male; Nanostructures; Oligosaccharides; Ophthalmic Solutions; Particle Size; Permeability; Rabbits; Thiazoles | 2017 |
Release Properties and Cellular Uptake in Caco-2 Cells of Size-Controlled Chitosan Nanoparticles.
Topics: Biological Transport; Caco-2 Cells; Cells; Chemistry, Pharmaceutical; Chitosan; Coumarins; Drug Carriers; Humans; Nanoparticles; Particle Size; Resveratrol; Stilbenes; Thiazoles | 2017 |
MHI-148 Cyanine Dye Conjugated Chitosan Nanomicelle with NIR Light-Trigger Release Property as Cancer Targeting Theranostic Agent.
Topics: Animals; Carbocyanines; Cell Line; Chitosan; Coloring Agents; Coumarins; Humans; Hyperthermia, Induced; Light; Mice, Inbred BALB C; Mice, Nude; Micelles; Nanoparticles; Neoplasms; Paclitaxel; Phototherapy; Spectroscopy, Near-Infrared; Theranostic Nanomedicine; Thiazoles; Tissue Distribution | 2018 |
UHPLC/MS Identifying Potent α-glucosidase Inhibitors of Grape Pomace via Enzyme Immobilized Method.
Topics: Acetates; alpha-Glucosidases; Benzofurans; Catechin; Chitosan; Chromatography, High Pressure Liquid; Coumarins; Enzymes, Immobilized; Glucosides; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Mass Spectrometry; Plant Extracts; Polymers; Stilbenes; Vitis | 2018 |
Development of photo and pH dual crosslinked coumarin-containing chitosan nanoparticles for controlled drug release.
Topics: Chitosan; Coumarins; Cross-Linking Reagents; Delayed-Action Preparations; Drug Carriers; HeLa Cells; Humans; Hydrogen-Ion Concentration; Nanoparticles; Photochemical Processes | 2018 |
Melamine-modified chitosan materials: An efficient and recyclable bifunctional organocatalyst for green synthesis of densely functionalized bioactive dihydropyrano[2,3-c]pyrazole and benzylpyrazolyl coumarin derivatives.
Topics: Catalysis; Chemistry Techniques, Synthetic; Chitosan; Coumarins; Green Chemistry Technology; Kinetics; Pyrazoles; Triazines | 2019 |
Chitosan oligosaccharide enhances binding of nanostructured lipid carriers to ocular mucins: Effect on ocular disposition.
Topics: Administration, Topical; Animals; Antineoplastic Agents, Phytogenic; Chitosan; Coumarins; Drug Carriers; Drug Delivery Systems; Etoposide; Eye; Lipids; Mucins; Nanostructures; Oligosaccharides; Rabbits; Rats; Rats, Sprague-Dawley; Tissue Distribution; Toxicity Tests | 2020 |
Osthole-loaded N-octyl-O-sulfonyl chitosan micelles (NSC-OST) inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in rats.
Topics: Animals; Bone Resorption; Cell Differentiation; Chitosan; Coumarins; Female; Humans; Mice; Micelles; NF-kappa B; Osteoclasts; Osteogenesis; Osteoporosis; Ovariectomy; RANK Ligand; Rats; RAW 264.7 Cells; Signal Transduction | 2020 |
Chitosan grafting coumarin-3-carboxylic acid fluorescent fiber with enhanced strength prepared by in-situ wet-spinning.
Topics: Chitosan; Coumarins; Tensile Strength | 2023 |